SAIC Stock Forecast & Price Target

Science Applications Intl is positioned favorably because it is delivering stronger-than-expected revenue growth, with FQ2 revenue of $1.88b up 6.3% y/y and organic growth of 5%, while Defense and Intelligence and Civilian both outperformed estimates. The company also showed improving execution in margins and cash generation, as Adj. EBITDA reached $193m, Adj. EPS was $2.38, and FCF was $131m, alongside raised FY27 guidance for revenue, EBITDA, and EPS. Its positive outlook is further supported by normalized on-contract growth, a robust RPO base that covers current-year revenue guidance, and a multiyear margin-improvement plan targeting about $150m of annual run-rate savings.

Science Applications Intl is viewed negatively because its next-twelve-month remaining performance obligations were only roughly flat year over year at $4.8 billion and, despite a guidance raise, the company is still embedding unusually high contingency into revenue expectations to avoid missing targets. Its core business has struggled to generate organic growth over the past five years, and the current portfolio is described as structurally slower growth and lower margin, which limits upside versus Government Services peers. Additional pressure comes from relatively high leverage, pricing competition, and reliance on U.S. government agencies, leaving it exposed to budget disruptions, delayed awards, and contract-risk events such as the Vanguard/Evolve recompete.